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Abstract European and Italian legislation have banned use
of growth promoters in livestock since 1988, but epidemio-
logical data show that anabolic drugs are still being used
illegally. Recent surveys carried out on the cattle farms in
Northern Italy have confirmed the presence of growth-
promoting hormones. Authors report data on growth per-
formances in 80 Valle del Belice×Comisana weaned lambs
experimentally treated with 17 beta-estradiol with 0.5 ml
solution of oil Depot Estradiol ® (containing 5 mg of 17β-
estradiol valerate) by intramuscular injection into the thigh.
The experiment was founded by the National Ministry of
Health, to validate histological test for surveillance and
control of growth-promoting hormones in sheep. This study
confirmed the strong correlation between clinical and ana-
tomopathological features and growth performances of trea-
ted animals. Otherwise, no significant differences were
found on in vivo performance of the lambs. Estradiol treat-
ment showed heavier shoulders and necks on treated lambs,
while the loins were significantly lighter. Moreover, lamb-
estradiol-treated groups showed lower separable and insep-
arable fat percentage than lamb-control groups.
Keywords Growth hormone . 17 Beta-estradiol . Growth
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Introduction
EU and Italian legislation (Italian D.Lgs. n. 336/99 and UE
Directive n. 96/22/CE) banned the use of growth hormones
in livestock in 1988. Directive 97/EC (2008) specifically
forbade 17 β-estradiol in food-producing animals due to its
potential carcinogenicity (Laviolette et al. 2010; Yu 2002;
Newbold and Liehr 2000).
Despite this regulation, EU data confirm that anabolic
drugs are still being used illegally as shown by constant high
sales of anabolic drugs in the livestock sector (Reig and
Toldrá 2009).
The laboratory tests used for detection of these undesir-
able residues display low sensitivity (Ministry of Health
2009). Moreover, the metabolization of new anabolic cock-
tails is rapid, which means that positive results are rarely
obtained (Courtheyn et al. 2002). Some surveys carried out,
at slaughterhouse, have confirmed the presence of growth-
promoting hormones by histological lesions, in target organs
(sexual accessory glands, thymus, thyroid; Reig and Toldrá
2009).
Histology represents an effective screening test for
slaughterhouse control, identifying those herds where there
is illegal use of anabolic drugs (Pezzolato et al. 2011). In
fact, a standardized histological test was added to the official
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surveillance national plan in 2008; while this histological
approach has been applied in cattle in some EU countries,
no data are available for small ruminants.
In the EU countries, 159 millions of sheep and 18
millions of goats are reared, mainly in Mediterranean
countries. In Italy, the current demand for small ruminant
meat exceeds internal supply, so there is a significant import
of sheep meat (live lambs and carcasses), which requires an
efficient surveillance system in order to monitor health and
quality of meat products (ERSAF 2008). In Sicily, dairy
sheep production represents an important resource for the
economy of hilly and mountainous areas, where other eco-
nomical activities are difficult to be developed (Scintu and
Piredda 2007). The major advantage of sheep, in our agri-
cultural system, is its ability to utilize pasture to produce
milk, meat, and wool.
In tropical and subtropical countries (including the
Mediterranean basin), there is no reported evidence of treat-
ment with anabolic substances in small ruminant meat farm-
ing. Actually, the traditional production, still classifiable as
“pastoralism” in these countries, does not concern this kind
of practice. Nevertheless, the new global market has stimu-
lated meat trades among several countries; in Sicily where
we record, for internal consumption, more than 25% of total
lamb meat imported from Eastern Europe (ERSAF 2008).
This massive flow of import live animals and carcasses
needs to implement a specific surveillance to estimate the
potential risk for consumers.
In this study, in order to investigate the effects of anabolic
treatment in lambs and to strengthen surveillance tools for
sheep meat production, authors collected data on growth
performance to be related to histological changes, observed
in heavy lambs, experimentally treated with 17 beta-estradiol.
Materials and methods
Sheep farming and feeding
The trial was conducted at an experimental station located in
Western Sicily between December and April and lasted
105 days. A total number of 80 Valle del Belice ×
Comisana weaned lambs were shared in four homogeneous
groups according to age (55±10 days), sex, and body
weight. The mean body weight for each group were similar
(16.51±0.77 kg for male lamb-control group, 15.57±
1.12 kg for female lamb-control group, 17.03±1.12 kg for
male lamb-estradiol-treated group, 15.82±1.07 kg for fe-
male lamb-estradiol-treated group). Lambs were slaughtered
at 160 days of age, when sheep reach commercial weight,
requested by our internal market (about 35 kg). All lambs
were fed with vetch and oat hay (crude protein010.31% on
dry matter (DM), neutral detergent fiber057.86% on DM)
offered ad libitum and 520 g/head/day of commercial con-
centrate (CP020.37% on DM, ether extract02.32% on
DM); freshwater was always available. For each group,
daily fed intake (offered minus residual) was recorded
weekly; hay and concentrate were analyzed for chemical
composition monthly. All lambs were weighted at the be-
ginning, at the end of treatment, and monthly.
All experimental procedures were designed in order to
avoid any animal distress and according to the European
(EC Directive 86/609/EEC for animal experiments) and
Italian animal health and well-being regulation.
Experimental treatment with 17 β-estradiol
The animals were monitored daily for clinical signs and
behavioral abnormalities occurring during the period of
the experimental trial. Any deviation from physiology
was noted in a clinical form with special reference to
under development, expressed as a percentage relative to
control groups (percent size improvement). After 54 days
from the start of the study, two groups of 20 lambs
(male lamb-estradiol-treated group and female lamb-
estradiol-treated group) were both treated with 0.5 ml/
head solution of oil Depot Estradiol ® (containing 5 mg
of 17β-estradiol valerate) by intramuscular injection into
the thigh. The estradiol administration was repeated
weekly for four times. The control group lambs were
injected with placebo (saline solution 0.5 ml per head).
The treatment was stopped 20 days before slaughtering.
Estradiol dose utilized (5 mg/head) was established
according to project guidelines, in order to obtain signif-
icant histological changes in target organs.
Slaughter data
The animals were slaughtered at 160 days of age. They were
fed until 12 h before slaughtering, and then stunned and bled
out. The gastrointestinal content was removed to calculate
empty body weight. At necropsy, macroscopic changes of
target organs (prostate, bulbo-urethral glands, ovary, udder,
Bartolin’s glands) and of thymus, hearth, lung, liver, spleen,
adrenal glands, and striated muscle were examined. After
anatomopathological evaluation, all samples were immedi-
ately fixed in 10% buffered formalin. The tissue samples
were later processed routinely, sectioned at 5 μm, and
stained with hematoxylin-eosin as standard procedures.
Sections were examined by light microscopy in order to
evaluate histological changes to be related to anabolic treat-
ment. The carcasses were split and the right side was
weighed and sectioned into commercial cuts according to
Preziuso et al. (1999). The right proximal pelvic limb (sam-
ple cut) was removed from each carcass, and was dissected
according to European Association for Animal Production
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Guidelines (Working Group on Carcass Evaluation; Fisher
and De Boer 1994) to determine the lean meat percentage,
fat, bone, and other tissues. After pelvic limb dissection,
meat was immediately homogenized and lyophilized. Dry
matter (at 105°C), fat extracted (with petroleum ether
Soxhlet apparatus), ash (at 525°C) and protein (by the
Kjeldhal procedure) were determined (AOAC 2003) in the
lyophilized samples.
Statistical analysis
All data were analyzed with a statistical two-factor model of
analysis of variance with interaction; the fixed factors were
sex and group. Least square means were compared with
Student’s t test. Statistical analysis was carried out, using
the general linear model of SAS software (SAS 2004).
Results
Clinical data, pathology, and histology
Clinical changes started to be visible after the third injection
of estradiol valerate. In treated female group, mammary
glands were all enlarged by 20% compared with udder of
control female group and nipples looked similar to an adult
lactating ewe. Sexual behavior was aroused and they behave
like adults during the reproductive season. Nevertheless,
there were no clinical changes in the control group.
The anatomopathological examination showed a general
enlargement of target glands, in all treated lambs: bulbo-
urethral glands and prostate for males, ovaries and genital
tract for females. Identification and inspection of Bartolin’s
glands were often difficult or inconclusive because the
Bartolin’s glands in sheep are only present in one animal
out of five (Barone 2003).
Histological changes of treated animals showed marked
metaplasia of prostatic tissue surrounding urethra lumen and
bulbourethral glands. In control animals, treated with place-
bo, there were no remarkable histological changes of the
prostate, bulbo-urethral glands, ovary, udder, Bartolin’s
glands, although in some cases they showed a moderate
hyperplasia of the urethra.
In vivo performance and carcass characteristics
The voluntary feed intake of dry matter is reported in Table 1.
The hay/concentrate ratio is 1.7 without significant differences
between groups. Daily gain, did not show any differences
between sex and between groups. As regards the food con-
version ratio, no significant differences were found too.
The in vivo lamb performance is reported in Table 2. At
the start of trial, males were heavier than females but no
significant differences were found between control and
Table 1 Voluntary feed intake
of lambs Female Male
Control Treated Control Treated
Hay intake (g/head/day of DM) 846 727 846 727
Concentrate intake (g/head/day of DM) 470 466 470 466
Dry matter intake (g/head/day) 1316 1.193 1316 1.193
Daily gain (g/day) 147 115 151 160
Food conversion ratio 8.95 10.38 8.72 7.46
Table 2 In vivo lambs performance (LSM±ES)
Female Male Significance
Control Treated Control Treated S G S×G
BW start the trial (kg) (A) 15.57±1.12 15.82±1.07 16.51±0.77 17.03±1.12 NS NS NS
BW start treatment (kg) (B) 23.50±1.34 22.04±1.29 24.66±0.93 25.65±1.12 * NS NS
BW end trial (kg) (C) 30.05±1.52 28.15±1.45 33.55±1.05 32.91±1.12 ** NS NS
Daily gain (kg/day) before treatment: (B−A)/54 0.147±0.01 0.115±0.01 0.151±0.01 0.160±1.12 * NS NS
Dailygain(kg/day)after treatment: (C−B)/51 0.128±0.01 0.120±0.01 0.174±0.01 A 0.142±1.12 B ** * NS
BW body weight, S sex, G group, S×G sex×group, NS not significant
On the row, different letters shown significant differences for P<0.01
*P<0.05, **P<0.01
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treated groups. In the first period, before treatment with
estradiol (lasting 54 days), daily gains ranged from 115 to
160 g/head/day but no significant differences were found
between groups. Instead, during the experimental period of
51 days (estradiol treatment), male-treated group showed
lower significant daily gain (P<0.01) than male control
group; while no significant differences were found between
the two female groups.
Results from slaughter house are reported in Table 3. The
effect of treatment was showed only for some anatomic
parts: hide plus limbs that resulted heavier than control
groups. Moreover, the estradiol treatment determined
shoulders and necks heavier in treated males and females,
while the loins resulted lighter, expressed as percent of
right side. The interaction between sex and group was
significant only for the shoulders, where the estradiol
treatment determined an increase of shoulders incidence
only for the female lambs. Results showed as the estra-
diol produced a negative effect on meaty cuts. Tissue
composition data and chemical composition of pelvic
limb meat are reported in Table 4. Treated lambs resulted
less fat than control lambs, showed lower separable fat
percentage and a lower ether extract percentage of pelvic
limb meat. Otherwise, protein and water percentages in
pelvic limb of treated lambs (males and females) resulted
higher than control lambs.
Table 3 Slaughter and dissection data (LSM±ES)
Female Male Significance
Control Treated Control Treated S G S×G
Slaughter weight (kg) 27.64±1.43 27.33±1.43 30.52±0.97 31.90±0.97 ** NS NS
EBWa (kg) 25.00±1.31 23.80±1.26 26.54±0.88 2729±0.88 * NS NS
Hide+limbs (% EBW) 13.53±0.40 14.62±0.39 13.86±0.27 14.32±0.27 NS * NS
Head (%EBW) 6.50±0.19 6.79±0.18 7.07±0.13 6.98±0.13 * NS NS
Organsb (%EBW) 4.48±0.18 4.70±0.18 4.80±0.13 4.87±0.13 NS NS NS
Carcass (kg) 12.82±0.91 12.34±0.91 12.60±0.91 13.70±0.91 NS NS NS
Dressing (%) 49.76±1.04 51.19±1.04 49.75±1.04 51.63±1.04 NS NS NS
Right side RS (kg) 6.41±0.46 6.17±0.46 6.30±0.46 6.85±0.46 NS NS NS
Shoulder (% RS) 18.08±0.34A 19.42±0.34B 18.67±0.34AB 18.60±0.34AB NS * *
Pelvic limb (% RS) 28.97±0.51 29.76±0.51 30.17±0.51 30.39±0.51 * NS NS
Bacon (% RS) 3.76±0.21 3.41±0.21 3.51±0.21 3.29±0.21 NS NS NS
Loin (% RS) 12.17±0.59 10.15±0.59 10.95±0.59 9.60±0.59 NS ** NS
Neck (% RS) 9.04±0.43 10.51±0.43 8.67±0.43 11.19±0.43 NS *** NS
Steak+brisket(% RS) 26.25±0.54 25.15±0.54 27.03±0.54 26.41±0.54 * NS NS
On the row, different letters shown significant differences for P<0.01
NS Not significant
*P<0.05, **P<0.01, ***P<0.001
a Empty body weight
b Lungs, trachea, heart, liver
Table 4 Tissue composition and
meat chemical composition of
pelvic limb (LSM±ES)
NS not significant
*P<0.05, **P<0.01,
***P<0.001
Female Male Significance
Control Treated Control Treated S G S×G
Muscle (%) 56.48±1.78 56.77±1.78 52.71±1.78 54.26±1.78 * NS NS
Fat (%) 11.08±0.92 8.58±0.92 10.59±0.92 8.87±0.92 NS * NS
Bone (%) 30.87±2.17 27.44±2.17 32.66±2.17 30.95±2.17 NS NS NS
Other tissues (%) 0.80±0.09 0.31±0.09 0.86±0.09 0.26±0.09 NS *** NS
Water (%) 73.48±0.87 75.90±0.77 73.50±0.94 76.26±0.73 NS ** NS
Protein (% DM) 85.40±0.68 85.45±0.68 85.81±0.68 87.93±0.68 NS * NS
Ether extract(%DM) 10.04±0.83 7.30±0.73 9.00±0.89 5.59±0.69 NS *** NS
Ash (% DM) 4.98±0.16 4.91±0.14 4.74±0.17 5.18±0.13 NS ** NS
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Discussion
The in vivo performance of the lambs showed no significant
differences between groups, but the feed conversion ratio
was higher than that reported in previous studies (Bonanno
et al. 2011) on the same breed. The body weight recorded
was in accordance with other studies on the same breed
(Pace et al. 2006).
The results obtained for slaughter weight and carcass are
comparable with slaughtered lambs of the same age
(Bonanno et al. 2011). As regards the lack of treatment
effect observed on growth performance of lambs, Meyer
(2001) reports that dose of estradiol can inhibit lambs
growth; high doses inhibit livestock growth, whereas low
doses enhance weight performance above 5%. Therefore,
we can assume that our dose was high for lambs, in partic-
ular for male lambs that showed the worst growth perfor-
mance. In fact, other authors (Pace et al. 2006), monitored
the beneficial anabolic action of the estrogens contained in
the subterranean clover (Mediterranean pasture), with a low
content of phytoestrogen (0.8 mg/g of dry matter), that
induced a significant improvement in animal weigh gain
(13.47%). The effect of treatment at slaughter and dissection
showed differences between groups only for some anatom-
ical parts: hide plus limbs, shoulders, loins, and necks. The
interaction between group and sex resulted statistically sig-
nificant only for shoulder percentage that resulted higher for
female treated lambs probably for different bone growth. As
far as tissue composition, results showed that treated lambs
were less fat than control lambs. These results are in accor-
dance with the international literature (Carson et al. 2001;
Scarth et al. 2009), that reports as internal body fat and
dissectible carcass fat deposition are reduced by hormone
administration.
Conclusions
This study confirms the strong correlation between clinical
and anatomopathological features, which have also showed
some interesting implications on growth performances of
treated animals. In term of carcass characteristics, intra
vitam and post mortem data showed that estradiol treatment
at this concentration did not influence the body weight and
weight gain of female lambs while induced a worsening of
male lambs performance. The treatment significantly influ-
enced some carcass cuts: as shoulder, loin, and neck. The
major effect of anabolic treatment was observed in tissue
composition and meat chemical composition, showing meat
with lower fat contents (separable and not) and higher water
and protein percentages.
In spite of scarce response in term of body weight, relate
to estradiol treatment in heavy lambs, the experiment
confirmed severe anatomopathological and histological
changes in target organs, as observed in cattle (Groot
2006). Future work will investigate same parameters in
groups of lambs treated with lower doses of hormone.
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